13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001848809
Total reported value
$164.2M
$164.2M
21 檔
95.6%
The Q1 2024 SEC filing reveals that Velan Capital Investment Management LP held a total portfolio value of $164.2M, covering 21 public equity positions.
During Q1 2024, Velan Capital Investment Management LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including ALIMERA SCIENCES INC, JSPR, PRAX) accounted for 95.6% of total reported equity market value during Q1 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Alimera Sciences Inc | Stock-Other | 24.10% | — | — | |
| 2 | JSPR | Jasper Therapeutics Inc | Stock-Other | 19.12% | -0.78% | — | |
| 3 | PRAX | Praxis Precision Medicines I | Stock-Other | 9.72% | -2.24% | +1.45% | |
| 4 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 9.55% | — | -33.33% | |
| 5 | HRTX | Heron Therapeutics Inc | Stock-Other | 8.79% | -2.11% | — | |
| 6 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 6.46% | — | — | |
| 7 | ADMA | Adma Biologics Inc | Stock-Healthcare | 4.58% | +1.27% | NEW | |
| 8 | TRML | Tourmaline Bio Inc | Stock-Other | 3.32% | — | — | |
| 9 | OTLK | Outlook Therapeutics Inc | Stock-Other | 2.71% | — | — | |
| 10 | ✓ | Optinose Inc | Stock-Other | 1.99% | — | -20.96% | |
| 11 | TELA | Tela Bio Inc | Stock-Other | 1.92% | — | +862.69% | |
| 12 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.76% | — | — | |
| 13 | AQST | Aquestive Therapeutics Inc | Stock-Other | 1.16% | — | — | |
| 14 | ✓ | Elevation Oncology Inc | Stock-Other | 1.16% | — | — | |
| 15 | NSPR | Inspiremd Inc | Stock-Other | 0.97% | -2.08% | — | |
| 16 | GERN | Geron CORP | Stock-Other | 0.75% | — | -35.77% | |
| 17 | MIST | Milestone Pharmaceuticals In | Stock-Other | 0.53% | — | — | |
| 18 | RZLT | Rezolute Inc | Stock-Other | 0.46% | +0.95% | — | |
| 19 | ✓ | Envveno Medical CORP | Stock-Other | 0.43% | — | — | |
| 20 | EYEGEUR | Kiora Pharmaceuticals Inc | Stock-Other | 0.35% | — | — | |
| 21 | ✓ | Aslan Pharmaceuticals LTD | Stock-Other | 0.17% | — | — |
According to official SEC Form 13F filings, Velan Capital Investment Management LP reported a total U.S. public equity portfolio value of $164.2M across 21 disclosed positions in Q1 2024.
During Q1 2024, Velan Capital Investment Management LP's top holdings by market value included ALIMERA SCIENCES INC (24.1%)、JSPR (19.1%)、PRAX (9.7%). The largest single position, ALIMERA SCIENCES INC, represented 24.1% of total portfolio value.
In Q1 2024, Velan Capital Investment Management LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.